Growth And Strong Remdesivir Covid-19 Sales Forecast By Gilead
The antiviral drug, remdesivir was a huge hit as a treatment for the seriously ill during the Covid-19 pandemic the world over, which drove the performance of its maker Gilead Sciences Inc to report a 26 per cent rise in its revenues for the fourth quarter of 2020 which was well above the estimates of…








